Corrigendum to ‘ROS mediated apoptotic pathways in primary effusion lymphoma: Comment on induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic pathways in primary effusion lymphoma’ [Transl. Oncol., 14 (7), 2021, Article 101061]

摘要

Pankaj Dwivedi is currently employee and shareholder of Genentech, Inc., a member of the Roche Group.